Viewing Study NCT01903928


Ignite Creation Date: 2025-12-26 @ 11:10 AM
Ignite Modification Date: 2026-01-13 @ 9:05 AM
Study NCT ID: NCT01903928
Status: COMPLETED
Last Update Posted: 2024-10-17
First Post: 2013-07-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate Safety and Tolerability of a Therapeutic Vaccine, ASP0113, in Subjects Undergoing Allogeneic Hematopoietic Cell Transplant
Sponsor: Astellas Pharma Inc
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2013-06-20
Start Date Type: ACTUAL
Primary Completion Date: 2015-01-19
Primary Completion Date Type: ACTUAL
Completion Date: 2015-01-19
Completion Date Type: ACTUAL
First Submit Date: 2013-07-01
First Submit QC Date: None
Study First Post Date: 2013-07-19
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-10-15
Last Update Post Date: 2024-10-17
Last Update Post Date Type: ACTUAL